EUVIMEDEUVIMED entdecken
Crossref

Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China

Lu Liu, Yuhua Ruan, Shiwen Chen, Hongyang Tang, Junhui Liu, Yu Jiang, Hengyan Pei, Tengda Huang, Guanghua Lan, Yihong Xie iD

Archives of Sexual Behavior · 2024-07 · 53 (7) · 2795-2806

DOI: 10.1007/s10508-024-02886-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Sexual Behavior, online erschienen am 07.06.2024. Verfasst von Lu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, 22, Shuangyong Road, Nanning, 530021, China. Hauptthemen laut MEDLINE: Homosexuality, Male, HIV Infections, Pre-Exposure Prophylaxis, Pyridones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of China, Guangxi Key Laboratory of AIDS Prevention Control and Translation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cabotegravir (CAB-LA), the first long-acting injectable pre-exposure prophylaxis (PrEP), has been approved for use in the USA and is not currently on the market in China. However, willingness to use CAB-LA and associated factors among men who have sex with men (MSM) have not yet been evaluated in China. A cross-sectional study was conducted in Guangxi, China, in 2022 recruiting 1,006 MSM. Their mean age was 30.2 years, 74.2% had college or above education, and 48.6% had a monthly income between 3,000 and 5,999 Chinese yuan (CNY). Most (73.4%) had previously heard of PrEP while few (8.3%) had ever used this type of preventative medication. Willingness to use CAB-LA was 79.8% and was positively associated with eight variables: younger age, being married to a woman, having a low monthly income, having six or more male partners in the past six months, having only regular male partners in the past month, having a high perceived risk of HIV infection, and history of using PrEP. Ten other variables were not significantly associated with willingness to use CAB-LA. Among 894 participants who were willing to use or did not definitely reject using CAB-LA, the main concerns about CAB-LA were its side effects (90.2%), efficacy (63.6%), and high cost (58.2%). Only 14.7% were willing to pay more than 1,200 CNY (~US$180) every two months to use CAB-LA. The preferred injection places were centers for disease control facilities, hospitals, and social organizations. Many (89.0%) said that they would recommend CAB-LA to their male sexual partners. We conclude that willingness to use CAB-LA was high among MSM in Guangxi. However, implementation of CAB-LA faces tough challenges due to its high cost and the low use of PrEP. Peer education may play a large role in the implementation of CAB-LA in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Homosexuality, MaleHIV InfectionsPre-Exposure ProphylaxisPyridonesHumansMaleChinaAdultCross-Sectional StudiesAnti-HIV AgentsPatient Acceptance of Health CareSexual PartnersHealth Knowledge, Attitudes, PracticeYoung AdultMiddle AgedDiketopiperazines

Stichwörter der Autor:innen

ChinaHIV/AIDSLong-acting injectable CabotegravirMen who have sex with menPre-exposure prophylaxis

Substanzen

cabotegravirPyridonesAnti-HIV AgentsDiketopiperazines

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, 22, Shuangyong Road, Nanning, 530021, China.
  • State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis an…
  • Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China.
  • Division of AIDS Control and Prevention, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Division of AIDS Control and Prevention, Guangxi Center for Disease Control and Prevention, Nanning, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, 22, Shuangyong Road, Nanning, 530021, China. gxxieyihong@163.com.

ORCID-Profile: Yihong Xie

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of China
  • Guangxi Key Laboratory of AIDS Prevention Control and Translation

Zitieren

APA

Liu, L., Ruan, Y., Chen, S., Tang, H., Liu, J., Jiang, Y., Pei, H., Huang, T., Lan, G., & Xie, Y. (2024). Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China. Archives of Sexual Behavior, 53(7), 2795-2806. https://doi.org/10.1007/s10508-024-02886-6

Vancouver

Liu L, Ruan Y, Chen S, Tang H, Liu J, Jiang Y, et al. Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China. Archives of Sexual Behavior. 2024;53(7):2795-2806. doi:10.1007/s10508-024-02886-6

BibTeX
@article{Liu2024,
  author = {Liu, Lu and Ruan, Yuhua and Chen, Shiwen and Tang, Hongyang and Liu, Junhui and Jiang, Yu and Pei, Hengyan and Huang, Tengda and Lan, Guanghua and Xie, Yihong},
  title = {Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China},
  journal = {Archives of Sexual Behavior},
  year = {2024},
  volume = {53},
  number = {7},
  pages = {2795--2806},
  doi = {10.1007/s10508-024-02886-6}
}
Kostenlos starten →